![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CONTROVERSIES, PROBLEMS & TECHNIQUES IN ENDOVASCULAR THERAPY
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||
Keynote Presentation |
What are the main messages from the AAA randomised trials (DREAM; EVAR-1 and –2) ? An analysis |
John Harris |
Presentations |
How have these trials influenced practice in UK & Europe? |
Irwin Mohan |
|
The DREAM and EVAR trials are not indicative of the real value of endografts for my practice |
Jim McKinsey (8 minutes) |
Keynote Presentation |
Progress with iliac branched devices and techniques. Are these ready for widespread use? |
Roy Greenberg
|
AAA controversies |
Each controversy will feature a lead-off faculty presenter, followed by panel discussion and audience participation |
|
Controversy 1 |
Should endoAAA repair be offered more liberally for small AAA? |
Luis Sanchez |
Controversy 2 |
Should AUI design grafts be abandoned? |
Andrew Hill |
Controversy 3 |
How should we manage renal artery stenosis in endoAA patients? |
Roy Greenberg |
Controversy 4 |
What improvements are needed to improve fenestrated endograft procedures? |
John Anderson |
Controversy 5 |
Can fenestrated endograft techniques be long-lasting and cost-effective? |
Bart Muhs |
Controversy 6 |
Should surgical or endovascular hypogastric artery revascularization be used more often with EVAR? |
Anthony Lee |
Controversy 7 |
What are the special considerations for use of iliac bifurcation / branch grafts? |
Michael |
Controversy 8 |
What is the role for visceral and/or great vessel debranching techniques for complex AAA? |
Andrew Hill |
Virtual Live Cases |
Virtual live case and problem case discussions (troubleshooting techniques for complex cases) |
Hugh Lukins |
|
Coffee Break |
|
|
||
Keynote Presentation |
Applications of Dynamic CT and MRA imaging. Consequences for endograft sizing and design? |
Hence Verhagen (10 minutes) |
Presentations |
Radiation exposure in endovascular repair of AAA |
Anna Farrar & |
|
Practical aspects of radiation protection |
Ken Thomson |
|
Lower limb MRA: Special applications |
Andrew Holden |
|
3D workstation planning for aortic procedures: Concepts and practical examples |
Roy Greenberg |
| Imaging Controversies |
Each controversy will feature a lead-off faculty presenter, followed by panel discussion and audience participation |
|
Controversy 1 |
How will 64-slice CT impact your practice? |
Roy Greenberg |
Controversy 2 |
Advances in image intensifier technology --how does this compare now to fixed systems for the operating room? |
Hence Verhagen |
Controversy 3 |
Should we be using ultrasound instead of CT for surveillance of AAA endografts? |
John Harris |
Virtual Live Cases |
Virtual live case and problem case discussions |
|
|
Lunch Break |
|
|
||
Keynote Presentation |
What have we learnt to date from carotid angioplasty trials and registries? |
Ron Fairman |
Carotid controversies |
Each controversy will feature a lead-off faculty presenter, followed by panel discussion and audience participation |
|
Controversy 1 |
What are the pros and cons of embolic protection techniques? Is embolic protection needed in all cases? |
Hence Verhagen |
Controversy 2 |
Are filters or occlusion balloons best? |
Michel Makaroun |
Controversy 3 |
When should we use reversal of flow for carotid protection? |
Luis Sanchez |
Controversy 4 |
Which stent for which lesion? Does it matter? |
Gishel New |
Controversy 5 |
What should you know about cerebral thrombolysis and neuro-rescue techniques? |
Geoff Parker |
Controversy 6 |
In-stent stenosis: What is the best management? |
Venkatesh Ramaiah |
Virtual Live Cases |
Virtual live case and problem case discussions (troubleshooting techniques for complex cases) |
|
|
Coffee Break |
|
|
||
Keynote Presentation |
The case for routine endovascular grafting for acute thoracic dissections |
Christoph Nienaber
|
Keynote Presentation |
Experience in China with endovascular grafting for thoracic dissections |
Jing Zaiping
|
Keynote Presentation |
Staged treatment strategy in endovascular management of complex aortic dissections |
Peter Mossop
|
Virtual Live Case |
Virtual live case: Hybrid treatment for complex TAA |
Ron Fairman |
Thoracic controversies |
Each controversy will feature a lead-off faculty presenter, followed by panel discussion and audience participation |
|
Controversy 1 |
Are there established criteria for selective endovascular grafting of acute thoracic dissections? |
Roy Greenberg |
Controversy 2 |
What size of thoracic aneurysm warrants treatment, and does the availability of endograft technology change this? |
Nick Hendel |
Controversy 3 |
Which aspects of current thoracic endograft technology need to be improved? |
Michel Makaroun |
Controversy 4 |
“Debranching” techniques for the thoracic arch: Is this the way to go for arch disease? |
Mark Farber |
Controversy 5 |
Should CSF drainage be used routinely for spinal cord protection in thoracic endograft cases? |
Anthony Lee |
Controversy 6 |
Are there any downsides to endograft use in acute traumatic disruption? Will the repair be durable? |
Hence Verhagen |
4.30 pm |
IES 2005 closing remarks |
Geoff White |
Click Here for Thursday 8th December
Click Here for Friday 9th December
Click Here to view the programme as a pdf file
For further information on any aspect of IES 2005, please contact the Secretariat:
Margaret Blackwell, IES 2005
Abacus Management Pty Limited
PO Box 77 Pymble NSW 2073 Australia
Phone +61 2 9983 9330 Fax +61 2 9983 9307
Website www.ies-sydney.com
Email abacus@abacusconf.com